February 2, 2026 · Form 4 insider transaction
Androski Lindsay bought 71,700 shares of ARBUTUS BIOPHARMA CORP at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant.; This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date.